Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Inactivated Influenza Vaccine”

Showing 7 of 0 results

Not applicableStudy completedNCT01568788
What this trial is testing

Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine

Who this might be right for
Human Influenza
Hualan Biological Engineering, Inc. 600
Testing effectiveness (Phase 2)Looking for participantsNCT06824519
What this trial is testing

Clinical Trials of Quadrivalent Influenza Vaccine

Who this might be right for
Influenza, Human
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 620
Testing effectiveness (Phase 2)Study completedNCT00518453
What this trial is testing

Immunogenicity of a Surface Antigen, Inactivated Influenza Vaccine Formulation 2007-2008

Who this might be right for
Influenza
Novartis Vaccines 129
Early research (Phase 1)Study completedNCT01676402
What this trial is testing

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

Who this might be right for
Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 316
Testing effectiveness (Phase 2)Study completedNCT02680002
What this trial is testing

Assess the Safety & Immunogenicity of Stored Inactivated Influenza H5N1 Virus Vaccine Given With & Without Stored MF59 Adjuvant

Who this might be right for
A/Vietnam/H5N1 Influenza Virus
Biomedical Advanced Research and Development Authority 422
Testing effectiveness (Phase 2)Study completedNCT01879553
What this trial is testing

Safety and Immunogenicity of a Subunit Trivalent Influenza Vaccine, Northern Hemisphere Formulation 2013/2014, in Healthy Adults Aged 18 Years and Above

Who this might be right for
Human Influenza
Novartis Vaccines 126
Testing effectiveness (Phase 2)Study completedNCT00522236
What this trial is testing

Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects

Who this might be right for
Influenza
Novartis Vaccines 56

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation